Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Total Debt (2019 - 2022)

Historic Total Debt for BioScience Health Innovations (BHIC) over the last 4 years, with Q2 2022 value amounting to $2893.0.

  • BioScience Health Innovations' Total Debt fell 8246.88% to $2893.0 in Q2 2022 from the same period last year, while for May 2022 it was $2893.0, marking a year-over-year decrease of 8246.88%. This contributed to the annual value of $17426.0 for FY2021, which is 12309.56% up from last year.
  • As of Q2 2022, BioScience Health Innovations' Total Debt stood at $2893.0, which was down 8246.88% from $2893.0 recorded in Q1 2022.
  • In the past 5 years, BioScience Health Innovations' Total Debt ranged from a high of $17426.0 in Q3 2021 and a low of $2893.0 during Q1 2022
  • Moreover, its 4-year median value for Total Debt was $7811.0 (2020), whereas its average is $10171.5.
  • In the last 5 years, BioScience Health Innovations' Total Debt soared by 15780.35% in 2021 and then crashed by 8246.88% in 2022.
  • Quarter analysis of 4 years shows BioScience Health Innovations' Total Debt stood at $6115.0 in 2019, then soared by 130.61% to $14102.0 in 2020, then rose by 23.57% to $17426.0 in 2021, then tumbled by 83.4% to $2893.0 in 2022.
  • Its last three reported values are $2893.0 in Q2 2022, $2893.0 for Q1 2022, and $17426.0 during Q4 2021.